Clinical Study to Evaluate the Implantation of the ActiGait Drop Foot Stimulator System

NCT01116466 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2021-08-26

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the efficacy and safety of surgical procedure involving ActiGait - implantable drop foot stimulator.

Conditions

Interventions

DEVICE

ActiGait

ActiGait - implantable drop foot stimulator

Sponsors & Collaborators

  • Otto Bock Healthcare Products GmbH

    lead INDUSTRY

Principal Investigators

  • David Liebetanz, MD · Medical University Georg-August-University Goettingen, Germany

  • Veit Rhode, MD · Medical University Georg-August-University Goettingen, Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-03-31
Completion
2010-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01116466 on ClinicalTrials.gov